CS logo
small CS logo
Peterborough City Hospital, Edith Cavell Campus; Oncology Department

Peterborough, United Kingdom
Teaching hospital in Peterborough, England
Edith Cavell Campus, Bretton Gate, Peterborough PE3 9GZ
612 Beds

About Peterborough City Hospital, Edith Cavell Campus; Oncology Department


Peterborough City Hospital is an acute teaching hospital on the Edith Cavell Healthcare Campus serving the city of Peterborough, north Cambridgeshire, areas of east Northamptonshire and Rutland. It is managed by North West Anglia NHS Foundation Trust.
There are 612 beds in Peterborough City Hospital, Edith Cavell Campus; Oncology Department.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Total Rows: 1

Clinical Trials at Peterborough City Hospital, Edith Cavell Campus; Oncology Department


During the past decade, Peterborough City Hospital, Edith Cavell Campus; Oncology Department conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails202000.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
2012-07-06
2017-03-10
Completed
719
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer
2014-07-14
2020-08-25
Completed
401
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer
2020-01-29
2025-09-19
Recruiting
400

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Peterborough City Hospital, Edith Cavell Campus; Oncology Department" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 6Hoffmann-La Roche: 6

Created with Highcharts 11.1.0Top CollaboratorsBreast International Group: 1Breast International Group: 1Genentech, Inc.: 1Genentech, Inc.: 1

Clinical Trials Conditions at Peterborough City Hospital, Edith Cavell Campus; Oncology Department


According to Clinical.Site data, the most researched conditions in "Peterborough City Hospital, Edith Cavell Campus; Oncology Department" are "Breast Cancer" (5 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Peterborough City Hospital, Edith Cavell Campus; Oncology Department" in a lesser frequency.

Clinical Trials Intervention Types at Peterborough City Hospital, Edith Cavell Campus; Oncology Department


Most popular intervention types in "Peterborough City Hospital, Edith Cavell Campus; Oncology Department" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Pertuzumab" (4 trials), "Trastuzumab" (4 trials), "5-Fluorouracil" (3 trials), "Cyclophosphamide" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Peterborough City Hospital, Edith Cavell Campus; Oncology Department


The vast majority of trials in "Peterborough City Hospital, Edith Cavell Campus; Oncology Department" are 5 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Peterborough City Hospital, Edith Cavell Campus; Oncology Department


Currently, there are NaN active trials in "Peterborough City Hospital, Edith Cavell Campus; Oncology Department". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Peterborough City Hospital, Edith Cavell Campus; Oncology Department, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Peterborough City Hospital, Edith Cavell Campus; Oncology Department, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1